期刊文献+

HPLC法测定载多柔比星氧化石墨纳米粒中的药物含量 被引量:1

Determination of Doxorubicin-loaded Graphite Oxide Nanoparticles by HPLC
暂未订购
导出
摘要 目的:建立氧化石墨(Graphene Oxide,GO)纳米粒中多柔比星(Doxornbicin,DOX)含量测定的高效液相色谱方法。方法:采用DiamonsilTM ODS-C_(18)色谱柱(250 mm×4.6 mm,5μm);流动相为十二烷基硫酸钠(SDS)溶液(2.88 g·L^(-1))-乙腈(1:1),加入0.5 ml·L^(-1)三乙胺和4 ml·L^(-1)磷酸;流速1.0ml·min^(-1);检测波长254nm。结果:制剂中辅料对DOX含量的测定无干扰,DOX的质量浓度在1~100μg·ml^(-1)。内线性关系良好(r=0.999 8),平均加样回收率为100.03%(RSD=1.5%,n=9)。GO纳米粒中DOX载药量高达2.35 mg·mg^(-1)。结论:含量测定方法准确可靠、简单易行,可用于氧化石墨纳米粒中多柔比星的含量测定。 Objective:To establish an HPLC method for the determination of doxorubicin(DOX)-loaded graphite oxide nanoparticles. Method:A DiamonsilTM ODS-C_(18) column(250 mm×4.6 mm,5μm) was used with aqueous SDS(2.88 g·L^(-1) )-acetonitrile (1:1) including 0.5 ml·L~triethylamine and 4 ml·L~phosphoric acid as the mobile phase at the flow rate of 1.0 ml·min^(-1). DOX was detected at 254 nm.Result:The linear range of DOX was 1-100μg·ml^(-1)(r =0.999 8).The average recovery was 100.03%(RSD = 1.5%,n =9).The DOX loaded in the graphite oxide nanoparticles was as high as 2.35 mg ·mg^(-1).Conclusion: The established method is accurate and simple in the content determination of DOX in graphite oxide nanoparticles.
出处 《中国药师》 CAS 2013年第3期334-336,共3页 China Pharmacist
基金 黑龙江省青年科学基金项目(编号:QC2011C104) 黑龙江省卫生厅科研课题(编号:2009-136)
关键词 多柔比星 氧化石墨 纳米粒 高效液相色谱法 含量测定 Doxorubicin Graphite oxide Nanoparticles HPLC Content determination
  • 相关文献

参考文献7

  • 1Ortner MA, Taha AA, Schreiber S, et al. Endoscopic injection of mitomycin adsorbed on carbon particles for advanced esophageal canc- er: a pilot study[J]. Endoscopy, 2004, 36(5) : 421-425.
  • 2Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment[J]. Cancer Res, 2008, 68(16) : 6652- 6660.
  • 3石淑贞,唐景玲,纪宏宇,史士强,吴琳华.HPLC法测定氧化石墨纳米粒中10-羟基喜树碱的含量[J].中国药师,2011,14(10):1475-1476. 被引量:3
  • 4Wang Y, Ding CX, Liu KJ, et al. Heparin-Paclitaxel Conjugates as Drug Delivery System: Synthesis, Self-Assembly Property, Drug Re- lease, and Antitumor Activity [ J]. J Bioconjug Chem, 2009, 20 (12) : 2214-2221.
  • 5应晓英,杜永忠,沈浩,等.HPLC测定多柔比星壳寡糖硬脂酸胶团中药物的含量[J].药物分析与检验,2009,26(5):388-390.
  • 6Rodrigues AS,Lopes AR,Leao A, et al. Development of an Analyti- cal Methodology for Simultaneous Determination of Vincristine and Doxorubicin in Pharmaceutical Preparations for Oncology by HPLC- UV[ J ]. Journal of Chromatographic Science, 2009, 47 (5) : 387- 391.
  • 7Mistiran AF, Dzarr AA, Gan SH, et al. HPLC method development and validation for simultaneous detection of Arabinoside-C and doxo- rubicin[J]. Toxicol Mech Methods, 2010, 20(8): 472-481.

二级参考文献6

  • 1GHANEH P, GREENHALF W, HUMPHREYS M, et al. Adenovirus mediated transfcr of p53 and p16 (INK4a) results in pancreatic cancer regression in vitro and in vivio [J]. Gene Ther,2001,8(3):199-208.
  • 2WU JX, WANG XP, XU JY, et al. Current study on epidemiology of pancreatic cancer [J]. J Clin (in Chinese),2000,17(3):189-191.
  • 3FLANDERS TY, FOULKES WD. Pancreatic adenocarcinoma: epidemiology and genetics [J]. J Med Genet, 1996,33(11):889-898.
  • 4LIONETTO R, PUGLIESE U, BRUZZI P, et al. No standard treatment is available for advanced pancreatic cancer [J].Eur J Cancer,1995,31A(6):882-887.
  • 5YEO CJ, CAMERON JL, LILLEMOE KD, et al. Panceraicoduodenetomy for cancer of the head of the pancreas: 201 patients [J].Ann Surg, 1995,221(6):721-731.
  • 6刘欣荣,王龙,卢懿,董晓辉,石莉,邓意辉.HPLC法测定羟基喜树碱人血清白蛋白纳米粒中的药物含量[J].沈阳药科大学学报,2009,26(1):48-51. 被引量:8

共引文献2

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部